Ticker Details
Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date:	March 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$486.62M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.77%
Avg Daily Range (30 D):	$0.51 | 8.12%
Avg Daily Range (90 D):	$0.83 | 5.48%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	8.16M
Avg Daily Volume (90 D):	4.24M

Trade Size
Avg Trade Size (Sh.):	162
Avg Trade Size (Sh.) (30 D):	130
Avg Trade Size (Sh.) (90 D):	114

Institutional Trades
Total Institutional Trades:	760
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$1.55M
Avg Institutional Trade (90 D):	$2.83M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.53M
Avg Closing Trade (30 D):	$2.18M
Avg Closing Trade (90 D):	$3.84M
Avg Closing Volume:	154.69K

News

Sep 14, 2026 @ 4:55 PM Deadline Alert: Capricor Therapeutics, Inc. (CAPR)... Source: Glancy Prongay Wolke & Rotter Llp

Sep 13, 2026 @ 2:20 PM מועד אחרון לת... Source: Rosen Law Firm

Sep 13, 2026 @ 2:20 PM CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL... Source: Rosen Law Firm

Sep 10, 2026 @ 9:54 PM CAPRICOR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL... Source: Rosen Law Firm

Sep 9, 2026 @ 5:40 PM Deadline Alert: Capricor Therapeutics, Inc. (CAPR)... Source: Glancy Prongay Wolke & Rotter Llp

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.7	$-.59
Diluted EPS		$-.7	$-.59
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-40.73M	$-33.94M
Operating Income / Loss		$-42.95M	$-36.77M
Cost of Revenue
Net Cash Flow		$-84.49M	$-182.43M
PE Ratio

Splits
Jun 05, 2019	1:10
Nov 21, 2013	1:50
Feb 09, 2007	1:10
Apr 05, 2005	1:20